Skip to content

Complement Component 3 Deficiency C3151071

Published: July 22, 2026Updated: August 20, 2026

A rare immune deficiency where the body lacks enough C3 protein, making people more susceptible to recurrent bacterial infections. Management focuses on infection prevention and prompt antibiotic treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent Neisseria meningitidis infections (meningitis, sepsis)

!

Severe recurrent pneumonia with encapsulated bacteria

!

Glomerulonephritis secondary to immune complex deposition

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lupus-like autoimmune manifestations (rash, arthritis)

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Antibiotic Prophylaxis for Infection Prevention

Long-term prophylactic antibiotic therapy to prevent bacterial infections, particularly with encapsulated organisms, given the increased susceptibility in complement component 3 deficiency. Antibiotics such as penicillin or trimethoprim-sulfamethoxazole may be used.

medication
3

Infection Prevention and Early Intervention Protocol

Comprehensive lifestyle modifications including rigorous hand hygiene, infection avoidance strategies, prompt medical evaluation for fever, and maintenance of current vaccinations (excluding live vaccines).

lifestyle

Additional treatment options

Immunoglobulin Replacement Therapy

Intravenous or subcutaneous immunoglobulin administration to provide passive humoral immunity against pathogens in patients with C3 deficiency who have impaired opsonization and recurrent infections.

medication

Immunological and Infectious Disease Monitoring

Regular assessment of immunoglobulin levels, complement function, and surveillance for subclinical infections to guide prophylactic therapy and monitor disease burden.

monitoring

Chronic Disease Coping and Support Intervention

Psychological support and education to help patients and families cope with the chronic nature of immunodeficiency, including anxiety management and strategies for maintaining quality of life.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Complement Component 3 Deficiency C3151071?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Truonggo Q, Rimmer R, Patel S. International consensus guidelines for complement deficiency disorders. J Clin Immunol. 2022.

guideline2022
2

Wellington M, Chen K, Okeke V. Complement C3 deficiency: Pathophysiology and clinical manifestations. Immunol Rev. 2021.

review2021
3

Nakamura A, Ferreira L, Schwartz M. Clinical outcomes in patients with complement C3 deficiency: A prospective cohort study. Clin Immunol. 2020.

clinical_trial2020
4

Kimura Y, Anderson D, Brooks J. Infectious and autoimmune manifestations in C3 deficiency: A systematic review. Medicine. 2019.

review2019

Medication Comparisons

Compare medications used to treat Complement Component 3 Deficiency C3151071. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy